派博傳思國際中心

標(biāo)題: Titlebook: Cyclin-Dependent Kinase (CDK) Inhibitors; Methods and Protocol Mar Orzáez,Mónica Sancho Medina,Enrique Pérez-Payá Book 2016 Springer Scienc [打印本頁]

作者: 卑賤    時間: 2025-3-21 16:54
書目名稱Cyclin-Dependent Kinase (CDK) Inhibitors影響因子(影響力)




書目名稱Cyclin-Dependent Kinase (CDK) Inhibitors影響因子(影響力)學(xué)科排名




書目名稱Cyclin-Dependent Kinase (CDK) Inhibitors網(wǎng)絡(luò)公開度




書目名稱Cyclin-Dependent Kinase (CDK) Inhibitors網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Cyclin-Dependent Kinase (CDK) Inhibitors被引頻次




書目名稱Cyclin-Dependent Kinase (CDK) Inhibitors被引頻次學(xué)科排名




書目名稱Cyclin-Dependent Kinase (CDK) Inhibitors年度引用




書目名稱Cyclin-Dependent Kinase (CDK) Inhibitors年度引用學(xué)科排名




書目名稱Cyclin-Dependent Kinase (CDK) Inhibitors讀者反饋




書目名稱Cyclin-Dependent Kinase (CDK) Inhibitors讀者反饋學(xué)科排名





作者: 清洗    時間: 2025-3-21 23:45

作者: fatty-streak    時間: 2025-3-22 01:22

作者: ADORN    時間: 2025-3-22 04:42
Models for the Study of the Cross Talk Between Inflammation and Cell Cycle, and their inhibitors in granulocytes and particularly the role of CDKs in the apoptosis pathway. This can be performed in vitro by isolation and use of primary granulocytes and in vivo using animal models of inflammatory disease in rodents and zebrafish. Some of the methods described here to assess
作者: 迅速成長    時間: 2025-3-22 11:33

作者: OCTO    時間: 2025-3-22 15:12

作者: OCTO    時間: 2025-3-22 17:44

作者: HAWK    時間: 2025-3-22 23:27

作者: 數(shù)量    時間: 2025-3-23 02:39
M. A. Habeeb Muhammed,Thalappil Pradeepstablished that Cdk1 is the only Cdk that is both essential and sufficient for driving the resumption of meiosis during mouse oocyte maturation. These genetic studies suggest a minimal-essential cell cycle model in which Cdk1 is the central regulator of cell cycle progression. Cdk1 can compensate fo
作者: Pigeon    時間: 2025-3-23 07:33
Tanzeela N. Raja,Albert M. Brouwer and their inhibitors in granulocytes and particularly the role of CDKs in the apoptosis pathway. This can be performed in vitro by isolation and use of primary granulocytes and in vivo using animal models of inflammatory disease in rodents and zebrafish. Some of the methods described here to assess
作者: MODE    時間: 2025-3-23 10:35
Semen O. Yesylevskyy,Alexander P. Demchenkoould be desirable to develop new tools that could facilitate a better understanding of the new insights into CDK functions and the mode-of-actions of CDKIs. In this context, this chapter describes an experimental approach to evaluate the metabolic consequences of CDKIs at the cellular level based on
作者: 營養(yǎng)    時間: 2025-3-23 14:32
1064-3745 aboratory protocols, and tips on troubleshooting and avoiding known pitfalls..Authoritative and thorough, .Cyclin-Dependent Kinase (CDK) Inhibitors: Methods and Protocols. is a useful tool for scientists interested in this research field..978-1-4939-4368-5978-1-4939-2926-9Series ISSN 1064-3745 Series E-ISSN 1940-6029
作者: Receive    時間: 2025-3-23 19:19
,Immunoprecipitation of Cdk–Cyclin Complexes for Determination of Kinase Activity,ated in tumor cells and to find specific inhibitors is an important goal to be achieved. We report here the current methods to determine their in vitro activity in order to facilitate the identification of specific inhibitors. Mainly, the activity can be determined by using immunoprecipitates from c
作者: 江湖郎中    時間: 2025-3-23 23:29
Expression and Purification of Recombinant Cyclins and CDKs for Activity Evaluation,ssociation with regulatory subunits named cyclins but their activities are also regulated by phosphorylation, acetylation, and the association with specific inhibitory proteins (CKIs). The activity of different Cdks is deregulated in many different type of tumors, and thus, Cdks are considered targe
作者: 冒號    時間: 2025-3-24 03:10
Expression and Purification of Recombinant CDKs: CDK7, CDK8, and CDK9, have been considered as drug targets and numerous efforts have been made to develop specific and potent inhibitors against them. The first step in all of these attempts and in many other biochemical analyses is the production of highly purified and reliable kinase, most frequently in a recombinant
作者: Inoperable    時間: 2025-3-24 08:14
Preparation of CDK/Cyclin Inhibitor Complexes for Structural Determination,nto the molecular determinants that govern their function mechanisms. The implementation of structural and functional CDK models towards developing novel anticancer strategies that will specifically target individual or multiple CDKs remains a critical need..More than 250 CDKs crystal structures are
作者: 顯而易見    時間: 2025-3-24 14:05

作者: Musket    時間: 2025-3-24 15:32

作者: grenade    時間: 2025-3-24 21:06
Identification of Cyclin A Binders with a Fluorescent Peptide Sensor,e emission increase upon interacting with the cyclin A Binding Groove (CBG). Competitive displacement assays of this probe allow the straightforward identification of peptides that interact with the CBG, which could potentially block the recognition of CDK/cyclin A kinase substrates.
作者: 難解    時間: 2025-3-25 03:12

作者: 聽寫    時間: 2025-3-25 03:43

作者: JOT    時間: 2025-3-25 09:38

作者: Cabg318    時間: 2025-3-25 12:42
Assessing Cell Cycle Independent Function of the CDK Inhibitor p21CDKN1A in DNA Repair, activity of CDK inhibitor. In addition to cell cycle, this protein regulates cell transcription, apoptosis, cell motility, and DNA repair. In particular, p21 may participate in different DNA repair processes, like the nucleotide excision repair (NER), base excision repair (BER), and double-strand b
作者: orthodox    時間: 2025-3-25 18:14
Drug Delivery Strategies of Chemical CDK Inhibitors,are not an exception. Nanotechnology may be able to solve some of the main problems limiting cancer treatments such as more specific delivery of therapeutics and reduction of toxic secondary effects. It provides new delivery systems able to specifically target cancer cells and release the active mol
作者: 慎重    時間: 2025-3-25 21:00

作者: interlude    時間: 2025-3-26 00:18
Evaluating Chemical CDK Inhibitors as Cell Death Inducers,tion and biological characterization of a highly potent, small-molecule pan-Cdk inhibitor, which inhibited Cdk1, 2, 4, 5, 6, and 9 with equal potency in the nM range. This compound inhibited multiple events in the cell cycle and induced cell death in human cancer cell lines as well as in peripheral
作者: HUSH    時間: 2025-3-26 07:09
Models for the Study of the Cross Talk Between Inflammation and Cell Cycle,tional activity via phosphorylation of RNA polymerase II and subsequent synthesis of, for example, inflammatory mediators and factors that influence the apoptotic process; including apoptosis of granulocytes such as neutrophils and eosinophils. Successful resolution of inflammation and restoration o
作者: 大吃大喝    時間: 2025-3-26 10:32

作者: 催眠藥    時間: 2025-3-26 15:22
Cyclin-Dependent Kinase (CDK) Inhibitors978-1-4939-2926-9Series ISSN 1064-3745 Series E-ISSN 1940-6029
作者: 松雞    時間: 2025-3-26 18:30

作者: Retrieval    時間: 2025-3-26 23:50
Adopting Flex for Multiple Devicesated in tumor cells and to find specific inhibitors is an important goal to be achieved. We report here the current methods to determine their in vitro activity in order to facilitate the identification of specific inhibitors. Mainly, the activity can be determined by using immunoprecipitates from c
作者: 誘騙    時間: 2025-3-27 01:47

作者: Recess    時間: 2025-3-27 07:14

作者: neologism    時間: 2025-3-27 12:43
Adobe Integrated Runtime on Mobile Devicesnto the molecular determinants that govern their function mechanisms. The implementation of structural and functional CDK models towards developing novel anticancer strategies that will specifically target individual or multiple CDKs remains a critical need..More than 250 CDKs crystal structures are
作者: archetype    時間: 2025-3-27 16:04
Springer Series on Fluorescencen. Abnormalities in CDKs activity and regulation are common features of cancer, making CDK family members attractive targets for the development of anticancer drugs. One of the main bottlenecks hampering the development of drugs for kinase is the difficulty to attain selectivity. A huge variety of s
作者: puzzle    時間: 2025-3-27 20:37

作者: 無法治愈    時間: 2025-3-27 22:54
Optimized UV/Visible Fluorescent Markerse emission increase upon interacting with the cyclin A Binding Groove (CBG). Competitive displacement assays of this probe allow the straightforward identification of peptides that interact with the CBG, which could potentially block the recognition of CDK/cyclin A kinase substrates.
作者: barium-study    時間: 2025-3-28 03:42
https://doi.org/10.1007/978-3-642-04702-2t of subpopulations of cells in specific stages of the cell cycle. These subpopulations are then used to study regulatory mechanisms of the cell cycle such as DNA synthesis, gene expression, protein synthesis, protein phosphorylation, protein degradation, and development of new drugs (e.g., CDK inhi
作者: BOLT    時間: 2025-3-28 08:56

作者: 預(yù)兆好    時間: 2025-3-28 13:50
Springer Series on Fluorescenceresulting in a cascade of cellular events prompting rapid cellular damage and suppression of kidney function. I/R injury, an inevitable impairment during renal transplant surgery, remains one of the major causes of acute kidney injury and represents the most prominent factor leading to delayed graft
作者: 具體    時間: 2025-3-28 18:28
Mykhaylo Yu. Losytskyy,Valeriy M. Yashchuk activity of CDK inhibitor. In addition to cell cycle, this protein regulates cell transcription, apoptosis, cell motility, and DNA repair. In particular, p21 may participate in different DNA repair processes, like the nucleotide excision repair (NER), base excision repair (BER), and double-strand b
作者: 江湖騙子    時間: 2025-3-28 21:15
https://doi.org/10.1007/978-3-642-04701-5are not an exception. Nanotechnology may be able to solve some of the main problems limiting cancer treatments such as more specific delivery of therapeutics and reduction of toxic secondary effects. It provides new delivery systems able to specifically target cancer cells and release the active mol
作者: 沉默    時間: 2025-3-29 01:32

作者: 遍及    時間: 2025-3-29 06:38

作者: TOXIN    時間: 2025-3-29 09:08

作者: Inflammation    時間: 2025-3-29 11:23

作者: magnate    時間: 2025-3-29 18:45
https://doi.org/10.1007/978-1-4939-2926-9CDK Inhibitor Proteins; CDK/Cyclin Pairs; Cell Culture; Cyclin-Dependent Kinase; Eukaryotic Cells
作者: JAUNT    時間: 2025-3-29 23:19
978-1-4939-4368-5Springer Science+Business Media, LLC 2016
作者: 技術(shù)    時間: 2025-3-30 01:24
Mar Orzáez,Mónica Sancho Medina,Enrique Pérez-PayáIncludes cutting-edge methods and protocols.Provides step-by-step detail essential for reproducible results.Contains key notes and implementation advice from the experts
作者: LEVER    時間: 2025-3-30 05:57

作者: 嬉耍    時間: 2025-3-30 10:34

作者: EWE    時間: 2025-3-30 15:57
1064-3745 ation advice from the experts.This volume contains a collection of relevant information for drug discovery in cell cycle research. Protocols to develop screening assays or to identify novel CDK inhibitors are discussed in the first part of the book. The second part of the book describes elaborate pr
作者: Ordeal    時間: 2025-3-30 16:58





歡迎光臨 派博傳思國際中心 (http://pjsxioz.cn/) Powered by Discuz! X3.5
精河县| 泸西县| 竹溪县| 辽宁省| 宽甸| 甘孜县| 琼海市| 新野县| 金坛市| 常熟市| 遵义市| 旌德县| 孟村| 古丈县| 绥芬河市| 镶黄旗| 乌恰县| 神农架林区| 泸定县| 安泽县| 福泉市| 泰宁县| 合作市| 光山县| 正蓝旗| 滨海县| 黎平县| 塔河县| 武宁县| 三穗县| 达日县| 连云港市| 桑日县| 临安市| 兰西县| 隆昌县| 曲阳县| 齐河县| 镇坪县| 峨边| 讷河市|